| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/18/2009 | US20090156494 Compositions and methods comprising gastrin compounds |
| 06/18/2009 | US20090156493 Urocortin-iii and uses thereof |
| 06/18/2009 | US20090156492 Methods of Using IL-1 Antagonists to Treat Autoinflammatory Disease |
| 06/18/2009 | US20090156491 Methods of inhibiting angiogenesis with fragments and homologs of troponin subunit i |
| 06/18/2009 | US20090156490 Peptides for diagnostic and therapeutic methods for celiac sprue |
| 06/18/2009 | US20090156489 Promotion of axonal regeneration |
| 06/18/2009 | US20090156488 Use of neuregulin for organ preservation |
| 06/18/2009 | US20090156487 Infant nutritional compositions for preventing obesity |
| 06/18/2009 | US20090156486 Production of human defensins in plant cells |
| 06/18/2009 | US20090156485 Method for coupling keratin-binding polypeptides with effector molecules which support carboxylic groups or sulfonic acid groups |
| 06/18/2009 | US20090156484 Use of Transferrins for Treating Destructive Inflammation of Mucous Membrane |
| 06/18/2009 | US20090156483 Analogs of Ghrelin |
| 06/18/2009 | US20090156482 External preparation, method of producing the same and usage for the same |
| 06/18/2009 | US20090156481 Use of Factor VIIa or Factor VIIa Equivalents for Preventing or Attenuating Haemorrhage Growth, and/or Oedema Generation Following Intracerebral Haemorrhage (ICH) in Patients Treated with Antiplatelet Therapy |
| 06/18/2009 | US20090156480 Biodegradable nanoparticle having t-cell recognizable epitope peptide immobilized thereon or encapsulated therein |
| 06/18/2009 | US20090156479 Methods and Means for Controlling the Endocytosis and Subsequent Degradation of a Cell Surface Protein |
| 06/18/2009 | US20090156478 Acylated GLP-1 Compounds |
| 06/18/2009 | US20090156477 Compositions and Methods for Regulating Inflammatory Responses |
| 06/18/2009 | US20090156476 Dimeric or Multimeric Microproteins |
| 06/18/2009 | US20090156475 Gene defects and mutant ALK kinase in human solid tumors |
| 06/18/2009 | US20090156474 Methods for treating obesity and obesity related diseases and disorders |
| 06/18/2009 | US20090156473 Pharmaceutical composition for the treatment of viral infections and/or tumor diseases by inhibiting protein folding and protein breakdown |
| 06/18/2009 | US20090156472 Cyclic Depsipeptides |
| 06/18/2009 | US20090156471 Use of anti-amyloid agents for treating and typing pathogen infections |
| 06/18/2009 | US20090156470 Interfering rna delivery system and uses thereof |
| 06/18/2009 | US20090156469 Methods of using [3.2.0] heterocyclic compounds and analogs thereof in treating waldenstrom's macroglobulinemia |
| 06/18/2009 | US20090156468 Use of human chorionic gonadotropin oral or injectable for metabolic syndrome treatment |
| 06/18/2009 | US20090156467 Thymic stromal lymphpoietin promoter and use therefor |
| 06/18/2009 | US20090156466 Characterization of a MEKK binding site and uses thereof |
| 06/18/2009 | US20090156465 Derivatives of beta-amino acid as dipeptidyl peptidase-iv inhibitors |
| 06/18/2009 | US20090156464 Pharmaceutical Compositions and Methods for Insulin Treatment |
| 06/18/2009 | US20090156463 Photokinetic delivery of biologically active substances using pulsed incoherent light |
| 06/18/2009 | US20090156462 Use of fibrous tissue inducing proteins for hernia repair |
| 06/18/2009 | US20090156460 Cationic betaine precursors to zwitterionic betaines having controlled biological properties |
| 06/18/2009 | US20090156459 Cationic-Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using the Same |
| 06/18/2009 | US20090156458 Assay for the detection of factors that modulate the expression of inagp |
| 06/18/2009 | US20090156457 Methods and means for screening for rhomboid activity |
| 06/18/2009 | US20090155928 Modulating robo: ligand interactions |
| 06/18/2009 | US20090155912 Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins |
| 06/18/2009 | US20090155899 Modified Chimeric Polypeptides with Improved Pharmacokinetic Properties |
| 06/18/2009 | US20090155897 Glycoprotein vi fusion proteins |
| 06/18/2009 | US20090155845 Molecules designated LDCAM |
| 06/18/2009 | US20090155843 Tnf antagonists |
| 06/18/2009 | US20090155834 Methods for identifying agents which alter histone protein acetylation, decrease aging or increase lifespan |
| 06/18/2009 | US20090155787 Mutations in the BCR-ABL tyrosine kinase associated with resistance to STI-571 |
| 06/18/2009 | US20090155774 Fluorescence resonance energy transfer screening assay for the identification of HIV-1 envelope glycoprotein-medicated cell |
| 06/18/2009 | US20090155772 Method for detecting nanbv associated seroconversion |
| 06/18/2009 | US20090155376 Protein hydrolysate with antidiabetic effect |
| 06/18/2009 | US20090155375 Compositions comprising a lipid and copolymer of styrene and maleic acid |
| 06/18/2009 | US20090155374 Bioactive agent, a low molecular weight chitosan, and a negatively charged third component; the chitosan dominates on the nanoparticle surface; enhanced permeability for paracellular drug delivery; chewable composition |
| 06/18/2009 | US20090155366 Osteoinductive materials |
| 06/18/2009 | US20090155364 Transdiscal administration of anti-TNFalpha antibodies and growth differentiation factors |
| 06/18/2009 | US20090155347 Cosmetic Composition for Stimulating the Synthesis of Proteins of the Basement Membrane |
| 06/18/2009 | US20090155344 Preparation and application of biodegradable-material-made microsphere vascular embolus containing liposome-encapsulated cytokines |
| 06/18/2009 | US20090155335 Non-leaching non-fouling antimicrobial coatings |
| 06/18/2009 | US20090155326 Layered drug delivery polymer monofilament fibers |
| 06/18/2009 | US20090155320 Method for producing hydroxyapatite particles |
| 06/18/2009 | US20090155306 Pamps, pathogen associated molecular patterns |
| 06/18/2009 | US20090155304 Modified Cyanovirin-N Polypeptide |
| 06/18/2009 | US20090155302 Antigen Arrays for Treatment of Allergic Eosinophilic Diseases |
| 06/18/2009 | US20090155293 Modified defensins and their use |
| 06/18/2009 | US20090155281 Methods of using antibodies that bind both bcma and taci |
| 06/18/2009 | US20090155278 Claudins as Markers for Early Detection, Diagnosis, Prognosis and as Targets of Therapy for Breast and Metastatic Brain or Bone Cancer |
| 06/18/2009 | US20090155273 Remedies for inflammatory bowel diseases |
| 06/18/2009 | US20090155272 Targeted pharmaceuticals and ligands |
| 06/18/2009 | US20090155271 pro-inflammatory cytokines, interleukins (IL-17A, IL-17F) |
| 06/18/2009 | US20090155270 Caspase inhibitors, especially caspase 3 inhibitors, for the treatment of influenza |
| 06/18/2009 | US20090155267 Molecule and chimeric molecules thereof |
| 06/18/2009 | US20090155266 Methods and Compositions Relating to Vascular Endothelial Growth Factor and TH2 Mediated Inflammatory Diseases |
| 06/18/2009 | US20090155264 Novel composition and methods for the treatment of psoriasis |
| 06/18/2009 | US20090155263 Compositions and methods for the treatment of immune related diseases |
| 06/18/2009 | US20090155260 Use of thymosin alpha 1 for the treatment of immunological diseases |
| 06/18/2009 | US20090155244 Methods and compositions for poxvirus a35r protein |
| 06/18/2009 | US20090155242 Polypeptide fusion comprising three nonoverlapping domains for use as tool in identifying modulator for enhancing immune response |
| 06/18/2009 | US20090155240 Dichloroacetate in combination with clinically high levels of cardioprotective or hemodynamic drugs |
| 06/18/2009 | US20090155239 Novel Protease, Microorganism Producing the Same, and Application Thereof |
| 06/18/2009 | US20090155238 Xylanases, nucleic acids encoding them and methods for making and using them |
| 06/18/2009 | US20090155237 Compositions and methods for bone strengthening |
| 06/18/2009 | US20090155236 Peptide sequence for modulation of delta protein kinase c |
| 06/18/2009 | US20090155234 Detection of mutations in a gene associated with resistance to viral infection, mx1 |
| 06/18/2009 | US20090155230 Novel genes and markers in essential arterial hypertension |
| 06/18/2009 | US20090155227 Combination growth factor therapy and cell therapy for treatment of acute and chronic heart disease |
| 06/18/2009 | US20090155219 Methods for damaging cells using effector functions of anti-gfra1 antibodies |
| 06/18/2009 | US20090155212 Immunostimulatory nucleic acids and cancer medicament combination therapy for the treatment of cancer |
| 06/18/2009 | US20090155211 Methods and Compositions for the Treatment of Autoimmune Disorders Using Clofarabine |
| 06/18/2009 | US20090155210 Oximyl hcv serine protease inhibitors |
| 06/18/2009 | US20090155209 Novel macrocyclic inhibitors of hepatitis c virus replication |
| 06/18/2009 | US20090155208 Methods and agents for modulating an immune response |
| 06/18/2009 | US20090155207 Use of Immunomodulatory Compounds for the Treatment of Transverse Myelitis, Multiple Sclerosis, and Other Disorders |
| 06/18/2009 | US20090155206 Methods, Compositions and Articles of Manufacture for Contributing to the Treatment of Cancers |
| 06/18/2009 | US20090155205 HUMAN ANTIBODIES THAT BIND HUMAN TNFa |
| 06/18/2009 | US20090155204 Methods for treating disorders involving monocytes |
| 06/18/2009 | US20090155203 Thrombopoietin mimetics |
| 06/18/2009 | US20090155200 Methods of promoting cartilage healing or cartilage integration |
| 06/18/2009 | US20090155178 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 06/18/2009 | US20090155174 RNA Interference Mediating Small RNA Molecules |
| 06/18/2009 | US20090155170 Annexin derivatives suitable for pretargeting in therapy and diagnosis |
| 06/18/2009 | US20090155164 Human c-fms antigen binding proteins |
| 06/18/2009 | DE102005009784B4 Peptid-Mimetika, Verfahren zur deren Herstellung, diese enthaltende pharmazeutische Zusammensetzung und deren Verwendung als Inhibitoren von Proteasomen und zur Induktion von Apoptose Peptide mimetics, methods for their preparation, pharmaceutical composition containing them and their use as inhibitors of proteasomes and inducing apoptosis |
| 06/18/2009 | CA2746551A1 Improved treatment and prophylaxis |